This study aims to understand better approaches for treating anemia in patients with CKD. By doing so, it aspires to make a significant contribution to the enhancement of patient care and overall outcomes.
Not Applicable
Not yet recruiting
- Conditions
- Health Condition 1: R718- Other abnormality of red blood cells
- Registration Number
- CTRI/2024/01/061359
- Lead Sponsor
- ational Institute of Pharmaceutical Education and Research, Mohali
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
A.All patients who are diagnosed with CKD with renal anemia & undergoing dialysis
B.Patient should have been on dialysis for at least 3 months.
C.Patients between 18-75 years will receive HIF-PHD inhibitors or ESAs
Exclusion Criteria
A.Inability to give informed consent
B.Patients unable to complete the interview
C.Psychiatric illness
D.History of malignancy
E.Any active or recent history of blood loss
F.Taking part in other drug studies
G.Pregnant and breastfeeding women
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method